Projects

Recurrent fractures in children with chronic kidney disease: A case series and review of literature

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2022

Project Lead

Dr. Nivedita Kamath

Authors

Dr. Nivedita Kamath, Dr. Binu Kurian, Dr. Arpana Iyengar

Project Status

completed